Clinical trial

Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery

NCT03446911

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2018-03-01Date precision: month

Registry last updated2018-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC, Stage Iunresolved

Interventions

SABRRADIATION

SABR + pembrolizumabCOMBINATION_PRODUCT

Sponsors & collaborators

Amsterdam UMC, location VUmclead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03446911 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.